0001644062-16-000002.txt : 20160415 0001644062-16-000002.hdr.sgml : 20160415 20160414174531 ACCESSION NUMBER: 0001644062-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160415 DATE AS OF CHANGE: 20160414 EFFECTIVENESS DATE: 20160415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dauntless 1, Inc. CENTRAL INDEX KEY: 0001644062 IRS NUMBER: 474032770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-241436 FILM NUMBER: 161572702 BUSINESS ADDRESS: STREET 1: 12520 HIGH BLUFF DRIVE STREET 2: SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-922-8919 MAIL ADDRESS: STREET 1: 12520 HIGH BLUFF DRIVE STREET 2: SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92130 D/A 1 primary_doc.xml X0707 D/A LIVE 0001644062 Dauntless 1, Inc. 12390 El Camino Real Suite 170 SAN DIEGO CA CALIFORNIA 92130 858-999-3053 DELAWARE None None Corporation true 2015 Joel Martin, Ph.D. c/o Dauntless 1, Inc. 12390 El Camino Real, Suite 170 San Diego CA CALIFORNIA 92130 Executive Officer Director David Kabakoff, Ph.D. 3000 Sand Hill Road Bldg. 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Director Michael Powell, Ph.D. 3000 Sand Hill Road Bldg. 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Director Pharmaceuticals Decline to Disclose 06b true 0001644062-15-000001 2015-05-14 false true false 0 12020235 7020235 5000000 The Total Offering Amount listed above includes $20,235.00 of Common Stock (all of which has been sold) and $12,000,000.00 of Series A Preferred Stock. false 5 0 0 0 false Dauntless 1, Inc. /s/ Joel Martin Joel F. Martin President and Chief Executive Officer 2016-04-13